Alerts will be sent to your verified email
Verify EmailPOLYMED
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
---|---|---|---|
Operational Metrics
|
|||
Unclassified
|
|||
R&D as a % of Total Sales
|
1.32 % | 0.15 % | n/a |
Financials
|
|||
5 yr Average ROE
|
16.32 % | 21.34 % | 31.8 % |
5yr average Equity Multiplier
|
1.41 | 1.49 | 1.27 |
5yr Average Asset Turnover Ratio
|
0.71 | 0.97 | 0.56 |
5yr Avg Net Profit Margin
|
16.39 % | 23.04 % | 40.4 % |
Price to Book
|
8.56 | 1.61 | 6.19 |
P/E
|
70.38 | 19.92 | 31.76 |
5yr Avg Cash Conversion Cycle
|
36.37 Days | -31.94 Days | 152.2 Days |
Inventory Days
|
56.63 Days | 43.46 Days | 35.71 Days |
Days Receivable
|
66.78 Days | 41.18 Days | 172.8 Days |
Days Payable
|
106.58 Days | 113.69 Days | 58.4 Days |
5yr Average Interest Coverage Ratio
|
21.4 | 14.83 | 328.3 |
5yr Avg ROCE
|
20.59 % | 7.45 % | 38.24 % |
5yr Avg Operating Profit Margin
|
25.03 % | 4.27 % | 47.2 % |
5 yr average Debt to Equity
|
0.19 | 0.06 | 0.03 |
5yr CAGR Net Profit
|
21.92 % | 38.52 % | 33.12 % |
5yr Average Return on Assets
|
11.54 % | 16.02 % | 23.56 % |
Shareholdings
|
|||
Promoter Holding
|
62.44 % | 74.56 % | 41.29 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
17.68 % | 0.0 | 2.86 % |
Change in Mutual Fund Holding (3 Yrs)
|
4.59 % | -2.23 % | 0.0 |
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|